Biofrontera (BFRI) Change in Acquisitions & Divestments (2023 - 2024)
Biofrontera's (BFRI) quarterly Change in Acquisitions & Divestments came in at $57000.0 in Q1 2024, down 10.94% quarter-over-quarter from $64000.0 in Q4 2023.
Biofrontera (BFRI) Change in Acquisitions & Divestments (2023 - 2024) Analysis & Trends
Biofrontera's Change in Acquisitions & Divestments history runs 2 years deep, the most recent figure standing at $57000.0 for Q1 2024.
- On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to $57000.0 in Q1 2024; TTM through Dec 2024 was $57000.0, a N/A change from a year earlier, with the FY2024 full-year figure at $57000.0, down 90.87% from the prior year.
- Change in Acquisitions & Divestments slipped to $57000.0 in Q1 2024 per BFRI's latest filing, from $64000.0 in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $382000.0 in Q3 2023 and bottomed at $57000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.88 Bn | 87.01 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn |
| 3 | Zoetis | 32.31 Bn | 30.37 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - |
| 7 | Viatris | 20.27 Bn | 18.47 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.92 Bn | 16.61 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn |
| 10 | Biofrontera | 10.99 Mn | 4.58 Mn | 14.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 57,000.00 |
| Mar 31, 2024 | 57,000.00 |
| Dec 31, 2023 | 64,000.00 |
| Dec 31, 2023 | 64,000.00 |
| Sep 30, 2023 | 382,000.00 |
| Sep 30, 2023 | 382,000.00 |